Conduit Pharmaceuticals Inc.
Save
6.56M
Market cap
Current P/E
Forward P/E

About

Health care
Sector
Biotechnology
Industry

Conduit Pharmaceuticals Limited operates as a clinical stage specialty biopharmaceutical company that provides unmet medical needs in the areas of autoimmune disease and idiopathic male infertility. The company was incorporated in 2022 and is based in Grand Cayman, Cayman Islands. Conduit Pharmaceuticals Limited operates as a subsidiary of Corvus Capital Limited.

Similar securities

Based on sector and market capitalization

Report issue